Karnataka government doctor suspended over taking bribes for surgery
According to information provided by department officials, Dr Narasimhamurthy was in-charge Taluk Health Officer at the health centre in Gudibande Town from August 2019. He has been at the post for approximately five years and ten months at the time of his suspension.Following the video's broadcast, the Chikkaballapura District Health Officer took immediate action by submitting a preliminary investigative report to the higher officials. It was recommended that a formal departmental inquiry be conducted into the matter. Subsequently, administrative officials constituted a specialised fact-finding team to investigate the allegations thoroughly.Upon examination of the available evidence and circumstances surrounding the case, there was strong and credible evidence that supported the bribery allegations.advertisementThe state government authorities decided to take disciplinary action against Dr Narasimhamurthy who was suspended from his official duties with immediate effect while the formal inquiry proceedings continue.The government invoked the provisions of Rule 10(3) of the Karnataka Civil Services (Classification, Control, and Appeal) Rules, 1957, which provides the legal framework for such disciplinary measures.Written by Rithu Pawar
IN THIS STORY#Kerala
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
4 hours ago
- The Hindu
Study alleging widespread antibiotic contamination in Indian rivers based on assumptions: Govt
A recent study alleging widespread antibiotic contamination in Indian rivers is based on "simulations and assumptions" and therefore, no conclusion on the issue can be drawn from it, the government has said. Replying to a question by Congress MP Pramod Tiwari in the Rajya Sabha on Friday, Union Minister of State for Environment Kirti Vardhan Singh said the study has cited its "own limitations of data availability". Study findings The study, conducted by researchers from McGill University, alleged that 80 per cent of the total length of rivers in India could be posing environmental and health risks due to antibiotic pollution. The media report, published on April 24, 2025, is based on a study titled 'Antibiotics in the global river system arising from human consumption' conducted by researchers from McGill University, Canada, and its "findings are based on simulations and assumptions", the minister said in a written reply. Furthermore, the minister informed that the government has not conducted any study on antibiotic contamination of rivers. Regarding the steps taken to regulate pharmaceutical waste and strengthen pollution control, Singh informed that the government launched the National Action Plan on Antimicrobial Resistance (NAP-AMR) in April 2017 to develop and implement strategic interventions to reduce the environmental impact of antimicrobial resistance through effective waste management and safe disposal of expired antimicrobials. He mentioned that the environment ministry issued a notification for the bulk drug and pharmaceutical industry in August 2021, classifying chemical and biological sludge or any residue generated from wastewater treatment as hazardous waste. These shall be managed in an environmentally sound manner in accordance with the Hazardous Waste and Other Wastes (Management and Transboundary Movement) Rules, 2016, Singh added. He highlighted that state pollution control boards have been empowered to prescribe additional relevant parameters and monitoring frequencies based on local conditions. The expired antimicrobials are disposed of by manufacturers or suppliers through incineration as per the Bio-medical Waste Management Rules, 2016, while sludge from effluent treatment plants is sent to common biomedical or hazardous waste treatment facilities for incineration or safe disposal. "To reduce antibiotic residue from effluent sources, industries are adopting reduce, recycle and reuse of treated effluent to maximise the extent of Zero Liquid Discharge to minimise the risk of pharmaceutical compound residues," the minister said.
Mint
5 hours ago
- Mint
India's booming beauty industry has a serious problem of quality. New rules target this menace
New Delhi: India has tightened rules to ensure stricter testing and labelling of cosmetics to enhance safety, check counterfeit products and clearly define spurious items, said two officials aware of the development. A failure to comply with the new rules introduced by the health and family welfare ministry will result in the suspension and cancellation of licences, according to the officials cited earlier and documents reviewed by Mint. The Cosmetics (Amendment) Rules, 2025 were finalized and notified on 29 July after a detailed consultative process with the relevant stakeholders and further consultation with the Drugs Technical Advisory Board, a top drug advisory panel, said the first official quoted earlier. The changes include setting up a dedicated Central Cosmetics Laboratory to test products before they hit the shelves. India's cosmetics market—including skin, hair and oral care, fragrances, and colour products—is estimated at $20 billion, growing at an annualized rate of 25%, according to India Brand Equity Foundation. New brands have been mushrooming as rising incomes spur consumption. However, that also brought a myriad of new products claiming to provide unverified benefits, especially when peddled by celebrities and influencers. Stricter rules aim to curb exaggerated claims and ensure higher standards that will also benefit exports. "The cosmetic industry in India is largely under-regulated, particularly concerning product claims. Unlike in many other countries, companies here can make unsubstantiated assertions—such as promising to make a person several shades fairer or claiming to stop hair fall—that are often misleading,' said Dr Dinesh Kumar Devaraj, president, Indian Association of Dermatologists, Venereologists & Leprologists (IADVL), Tamil Nadu. 'This is where regulatory checks are critically needed.' Queries sent to the health ministry spokesperson and cosmetic manufacturers, including Hindustan Unilever Ltd, on Friday remained unanswered. Cosmetics in India are regulated under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The Central Drugs Standard Control Organization (CDSCO) is the main regulatory body responsible for implementing the rules. 'Lots of clerical and administrative corrections have been made in cosmetics rules,' the first official quoted earlier said. 'These comprehensive measures signal a serious commitment by the government to prioritize consumer safety and bring greater transparency to India's cosmetics industry.' Manufacturers will now have to keep detailed records of all raw materials and manufactured batches for three years or six months after the batch expires, whichever is later. This improved record-keeping will significantly enhance the traceability of products in case of a safety concern. The new regulations require that labels on cosmetics to be exported meet the legal standards of the destination country. A cornerstone of the new policy is the Central Cosmetics Laboratory to test samples. It will also be an appellate laboratory, ensuring a centralized and rigorous approach to product quality. The rules, for the first time, empower the State Licensing Authority to suspend or cancel a license if a company fails to comply with any of its conditions or with any provision of the Act or the rules. This order will be issued in writing after giving the licencee an opportunity to show cause and be heard. However, a manufacturer whose licence is suspended or cancelled has the right to appeal the decision to the state government within 90 days, ensuring due process is followed. The new regulations specifically define 'spurious cosmetics' under section 17D of the Act, strengthening the government's ability to crack down on counterfeit items. That provides a stronger legal basis for regulatory bodies to crack down on such items. The rules also seek to streamline international trade. 'The cosmetic is meant for export, then the label on the package or container of cosmetic shall comply with the law of the country to which the cosmetic is to be exported,' the notification said. Similarly, a specific provision has been added to allow for a code number instead of the manufacturer's name and address on the label if the importer requires it. These changes are designed to protect consumers from unsafe and counterfeit cosmetic products while strengthening the regulatory framework, the second official quoted earlier said. According to the L'Oréal India spokesperson, the updated cosmetic regulations enhance clarity and compliance, '…particularly the provision for export labelling, which significantly streamlines international trade, benefiting our exports from India to 25 countries'. Citing that 95% of its products sold in India are locally manufactured, the spokesperson said these 'progressive changes further support our 'Make in India' endeavors and our mission to provide high-quality beauty solutions both domestically and internationally'. The industry has also come under scrutiny after complaints regarding mercury-based products, Mint reported earlier. Products such as skin-lightening creams, 'anti-ageing solutions' for freckles and dark spots and certain makeup items are known to contain the toxic element. Dr. Devaraj said another concern is the misuse of steroids in cosmetics for skin brightening, which can lead to significant dermatological damage. 'As a doctor, I can easily distinguish between skin that has been brightened by such steroid use and skin that is healthy,' he said. 'The issue of wrong or non-existent labelling also needs to be addressed. Furthermore, there is a complete lack of regulation on pricing, which allows for a dramatic disparity in costs for similar products.' The validation provided by celebrities and social media influencers heavily influences consumers, especially first-time buyers, according to him. 'Given our vast population, a small fraction of buyers can generate significant profit for a company, reducing the need for repeat business,' said Dr. Devaraj. 'This trend has been amplified by the rise in online sales and paid promotions post-Covid.'
Indian Express
a day ago
- Indian Express
Namma Metro transports human liver for transplant; becomes second metro network in country to ferry organ
In a first-of-its-kind development for the city, Bengaluru Metro Rail Corporation (BMRCL) facilitated the transportation of a donated human liver for transplant – marking Bengaluru's entry into a select list of cities leveraging rapid transit systems for life-saving medical emergencies. At 8.38 pm on Friday, an ambulance carrying the liver left Vydehi Hospital and reached Whitefield metro station, where a team comprising a doctor and seven medical personnel coordinated with BMRCL staff. The team was received by an Assistant Security Officer (ASO) and metro personnel, who helped with documentation and security procedures. The liver was transported on a metro train that departed Whitefield station at 8.42 pm and reached Rajarajeshwarinagar metro station by 9.48 pm. Upon arrival, another ASO and Metro staff ensured a smooth transition to a waiting ambulance, which took the organ to Sparsh Hospital for a critical transplant procedure. The distance between the two hospitals is 32 km, which takes roughly 1.5 hours to cover. 'We facilitated organ transport with passengers on board. We had given the medical professionals the last coach of the train. Most of the procedures and subsequent arrangements took place within minutes, spontaneously,' said a BMRCL official. BMRCL also stated that the entire operation was carried out as per the Joint Procedure Order (JPO) and guidelines issued by the Ministry of Housing and Urban Affairs (MoHUA). The successful execution of this mission makes Bengaluru only the second city in India to use a metro system for organ transport. In 2021, Hyderabad Metro facilitated the transport of a heart, harvested from a brain-dead donor. The organ was taken to Nagole metro station by ambulance and then transported on a non-stop, passenger-free metro train to Jubilee Hills Check Post station – covering 21 km in under 30 minutes. In 2023, MoHUA amended the Metro Railways (Carriage and Ticket) Rules, 2014, allowing the transport of human organs or tissues via metro, provided a hospital-authorised person carries them under the Transplantation of Human Organs and Tissues Act, 1994.
